Home / Products / Pediatric Range / Asth Mxl Sus
Click image to inspect pack details
Pediatric Range Marketed by Aerochem Neutron

Asth Mxl Sus

Formulation Code AC-410
Commercial Status Active Product Information Available

Product Overview & Formulation Profile

Composition: Montelukast 4mg + Levocetirizine 2.5mg (oral suspension, Pineapple Flavour). It combines Montelukast (leukotriene receptor antagonist) and Levocetirizine (second-generation antihistamine); each component acts on a different part of the clinical problem.

Montelukast is a leukotriene receptor antagonist that blocks cysteinyl leukotrienes involved in airway inflammation and bronchoconstriction. Levocetirizine is a second-generation H1-antihistamine.

ASTH-MXL is a prescription medicine from Aerochem Neutron's pediatric range, for use on the prescription of a registered medical practitioner.

Composition & Formulation Details

·       Allergic rhinitis (seasonal and perennial)

·       Allergic symptoms such as sneezing, runny nose and nasal congestion

·       Adjunctive management of allergic asthma

·       Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination


  • Allergic rhinitis (seasonal and perennial)
  • Allergic symptoms such as sneezing, runny nose and nasal congestion
  • Adjunctive management of allergic asthma
  • Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination.

Safety

·       Contraindicated in patients with known hypersensitivity to any component.

·       Montelukast carries a regulatory warning for neuropsychiatric events (including sleep disturbance, depression and suicidal thoughts); patients should report mood or behaviour changes.

·       May cause drowsiness; dose adjustment is needed in renal impairment.

·       Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.

Clinical Rationale: The mechanisms and labelled uses of montelukast, levocetirizine described here follow the US prescribing information (DailyMed). Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.

References 

·       DailyMed (US NLM) prescribing information – montelukast: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=MONTELUKAST

·       DailyMed (US NLM) prescribing information – levocetirizine: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=LEVOCETIRIZINE

Professional Product Enquiries

Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.

Product Information

Review verified active composition, strength, dosage form, and packaging details on this page.

View Specifications

Healthcare Professional Enquiry

Request formulation literature, technical specifications, or product communication from our commercial team.

Submit Product Enquiry

Commercial Supply Enquiry

Connect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.

Commercial Enquiry

Professional Product Information

This product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.

Product Enquiry

Request Formulation Details

Request information about Asth Mxl Sus for professional use.

Please enter the numeric sum to verify you are a human visitor.
Therapeutic Alternatives

Related Formulations

AEROFLOX PLUS Sus Formulation
ACDC DROP Formulation
NILLE P SYP Formulation
NILLE P DS Formulation
Product Information

Need specifications for this formulation?

Request verified product information for professional use, or send a separate business enquiry for manufacturing or partnership discussions.

WhatsApp: +91 9512047000